Contracts › 75F40122P00259
75F40122P00259: Optical Coherence Tomography (OCT) Retinal Imaging System
Awarded to L1 Enterprises Incorporated by Food and Drug Administration (FDA).
$143Kobligated
$151Kpotential value
18 October 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40122P00259 |
|---|---|
| Awardee | L1 Enterprises Incorporated |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 334516 Analytical Laboratory Instrument Manufacturing |
| PSC | 6640 Laboratory Equipment and Supplies |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 18 July 2022 to 18 October 2026 |
| Potential end | 18 October 2027 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 334516 contracts · All expiring contracts · USASpending record